SCHEMBL21851037

SCHEMBL21851037

CC(C)OC(=O)N1CCC2(CC1)C(=O)N(C)c1cnc3ccc(-c4ccc(F)nc4)cc3c12

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ATM Q13315 6/20 0.42
▸ PRKDC P78527 3/20 0.42
▸ MTOR P42345 5/20 0.36
▸ PIK3CA P42336 4/20 0.36
▸ ATR Q13535 2/20 0.36
▸ DYRK1A Q13627 3/20 0.34
▸ GSK3B P49841 2/20 0.34
▸ OPRD1 P41143 1/20 0.34
▸ OPRK1 P41145 1/20 0.34
▸ GPR119 Q8TDV5 2/20 0.33
▸ RET P07949 1/20 0.33
▸ MELK Q14680 1/20 0.33
▸ CLK2 P49760 1/20 0.32
▸ CLK3 P49761 1/20 0.32
▸ MAP3K11 Q16584 1/20 0.32
▸ PIK3CD O00329 1/20 0.32
▸ PIK3CB P42338 1/20 0.32
▸ PIK3CG P48736 1/20 0.32
▸ KCNH2 Q12809 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21851207 0.91 ATM (0.47) ATMPRKDCMTORPIK3CAATR
SCHEMBL21851136 0.88 PRKDC (0.44) ATMPRKDCMTORPIK3CAATR
SCHEMBL21851073 0.88 ATM (0.44) ATMPRKDCMTORPIK3CAATR
SCHEMBL21851077 0.85 PRKDC (0.42) ATMPRKDCMELK
SCHEMBL23615865 0.85 ATM (0.44) ATMPRKDCMTORPIK3CAATR
SCHEMBL21851038 0.84 MCL1 (0.41) ATMPRKDCMTORPIK3CAOPRD1
SCHEMBL21851039 0.84 ATM (0.52) ATMPRKDCMTORPIK3CAATR
SCHEMBL21851019 0.84 ATM (0.45) ATMPRKDCMTORATRDYRK1A
SCHEMBL21851056 0.83 ATM (0.46) ATMPRKDCMTORPIK3CAATR
SCHEMBL21851161 0.82 ATM (0.46) ATMPRKDCMTORATRDYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3845532-B1 QUINOLINO-PYRROLIDIN-2-ONE DERIVATIVE AND APPLICATION THEREOF MEDSHINE DISCOVERY INC (CN) 2022-12-21 — — EP disclosed
US-11230549-B2 Quinolino-pyrrolidin-2-one derivative and application thereof MEDSHINE DISCOVERY INC. (CN) 2022-01-25 — — US disclosed
US-20210380599-A1 QUINOLINO-PYRROLIDIN-2-ONE DERIVATIVE AND APPLICATION THEREOF MEDSHINE DISCOVERY INC. (CN) 2021-12-09 — — US disclosed
EP-3845532-A1 QUINOLINO-PYRROLIDIN-2-ONE DERIVATIVE AND APPLICATION THEREOF Medshine Discovery Inc. (CN) 2021-07-07 — — EP disclosed
WO-2020063855-A1 QUINOLINO-PYRROLIDIN-2-ONE DERIVATIVE AND APPLICATION THEREOF 南京明德新药研发有限公司 2020-04-02 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11230549-B2 Quinolino-pyrrolidin-2-one derivative and application thereof ATM, CHEK2, CHEK1 ATM 1/4885PRKDC 227/4885MTOR 274/4885
US-20210380599-A1 QUINOLINO-PYRROLIDIN-2-ONE DERIVATIVE AND APPLICATION THEREOF ATM, CHEK2, CHEK1 ATM 1/4885PRKDC 227/4885MTOR 274/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback